News About: Pharm. Industry
Ostec wins U.S. patent for new anticancer compounds
Ostec Inc., a local biopharmaceutical company, said Wednesday that it has recently obtained the U.S. patent for new anticancer compounds.
The patented compounds, which have been discovered through a 4-year intensiv...
Big five’s earnings fall 11% on government’s forced price cut for drugs
Korea’s five major drug companies saw their combined earnings drop 11 percent in 2012 from a year earlier, an online pharmaceutical information provider said yesterday, pointing to their troubles stemming from the gov...
Drug companies rush to hike prices
Pharmaceutical companies here are jumping on the bandwagon to hike prices of over-the-counter (OTC) drugs. This puts a heavier financial burden on households already grappling with shrinking incomes, growing debt and ...
Sanofi’s Korea-based affiliates move to new headquarters
Paris-based health care group Sanofi said Wednesday that four of its subsidiaries operating in Korea moved to a new building in Seocho-ku, Seoul.
The four affiliates are Sanofi Aventis Korea (pharmaceutical busines...
KPMA to beef up anti-dumping effort
The Korea Pharmaceutical Manufacturers Association (KPMA) has recently proposed a set of measures to the Ministry of Health and Welfare in a move to stem illegal dumping activities such as predatory pricing in hospita...
United Pharm to export anti-inflammatory drug to Europe
Korea United Pharm Inc. said on Feb. 6 that it will export its anti-inflammatory drug Clanza CR tablets (aceclofenac 200 mg) to Russia and four Eastern European countries under a distribution agreement with the world’...
Dong-A seeks overseas expansion
Top local drug maker Dong-A Pharmaceutical is ramping up its overseas expansion drive this year, with the aim to boost overseas growth.
The Seoul-based company, which already established subsidiaries, in the U.S. a...
Pfizer Korea, top sponsor of clinical trials in 2012
Pfizer Korea led any other companies in the number of clinical trials approved last year, according to the Korea Food and Drug Administration (KFDA).
The KFDA approved 46 clinical trials requested by Pfizer Korea. ...
Multinational clinical studies are increasing, KFDA says
The number of multinational clinical trials conducted by multinational pharmaceutical companies in Korea reached 303 last year, showing a 56-percent increase from a year earlier, according to the Korea Food and Drug A...
SK Chemicals seeks bigger market share in Europe
SK Chemicals, Korea’s leading pharmaceutical and chemical products manufacturer, is gearing up to boost its marketing activities in Europe with its dementia patch treatment, named SID710 (rivastigmine), was approved b...
